BMI1 and colorectal cancer: In colorectal cancer, miR-128-3p reverses oxaliplatin resistance in colorectal cancer through the downregulation of Bmi1 and MRP5, two genes involved in oxaliplatin-induced EMT (Liu et al. 2019).